(Q36445650)

14 August 2017

1 reference

title

Changing antiretroviral therapy in the setting of virologic relapse: review of the current literature (English)

1 reference

14 August 2017

0 references

anti-retroviral agent

0 references

author name string

Albert M L Anderson

series ordinal

1

1 reference

14 August 2017

John A Bartlett

series ordinal

2

1 reference

14 August 2017

publication date

1 July 2006

1 reference

14 August 2017

published in

Current HIV/AIDS reports

1 reference

14 August 2017

volume

3

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

79-85

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-006-0022-1

14 August 2017

exact match

0 references

cites work

Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness

1 reference

12 December 2020

Assessing Resistance Costs of Antiretroviral Therapies via Measures of Future Drug Options

1 reference

12 December 2020

Rates of spontaneous mutation among RNA viruses

1 reference

12 December 2020

Incidence of Discontinuation of Highly Active Antiretroviral Combination Therapy (HAART) and Its Determinants

1 reference

12 December 2020

Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy

1 reference

12 December 2020

Adherence assessment to highly active antiretroviral therapy

1 reference

12 December 2020

Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of

1 reference

12 December 2020

Nevirapine-resistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients

1 reference

12 December 2020

HIV-1 drug resistance evolution among patients on potent combination antiretroviral therapy with detectable viremia.

1 reference

12 December 2020

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

12 December 2020

The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study

1 reference

12 December 2020

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

1 reference

12 December 2020

Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance

1 reference

12 December 2020

Minimizing resistance consequences after virologic failure on initial combination therapy: a systematic overview

1 reference

12 December 2020

Duration of Highly Active Antiretroviral Therapy Regimens

1 reference

12 December 2020

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

1 reference

12 December 2020

Virological rebound after suppression on highly active antiretroviral therapy

1 reference

12 December 2020

HIV-1 pol replication capacity predicts disease progression

1 reference

12 December 2020

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.

1 reference

12 December 2020

Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients

1 reference

12 December 2020

A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir.

1 reference

12 December 2020

Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients.

1 reference

12 December 2020

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

12 December 2020

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients

1 reference

12 December 2020

How well do clinicians estimate patients' adherence to combination antiretroviral therapy?

1 reference

12 December 2020

Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART.

1 reference

12 December 2020

Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy

1 reference

12 December 2020

Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistance

1 reference

12 December 2020

Adherence to antiretrovirals in HIV disease

1 reference

12 December 2020

Evaluation of safety and efficacy of 3TC (lamivudine) in patients with asymptomatic or mildly symptomatic human immunodeficiency virus infection: a phase I/II study

1 reference

12 December 2020

Consecutive rebounds in plasma viral load are associated with virological failure at 52 weeks among HIV-infected patients

1 reference

12 December 2020

Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection

1 reference

12 December 2020

Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy

1 reference

12 December 2020

Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?

1 reference

12 December 2020

The effect of garlic supplements on the pharmacokinetics of saquinavir

1 reference

12 December 2020

Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.

1 reference

12 December 2020

Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen

1 reference

12 December 2020

10.1007/S11904-006-0022-1

Identifiers

DOI

1 reference

14 August 2017

1 reference